Perinatal Epigenetic Modifications Influencing Lifelong Metabolic and Cardiovascular Disease Susceptibility

Abstract

Background:

The perinatal period is a critical developmental window during which environmental exposures can induce epigenetic changes that impact long-term health outcomes. Alterations in DNA methylation, histone modification and the expression of non-coding RNAs have been linked to maternal nutrition, stress, obesity, diabetes, smoking and environmental pollutants, thus affecting fetal metabolic and cardiovascular programming.
Objective:
To assess the impact of perinatal epigenetic changes on the lifelong predisposition to metabolic and cardiovascular diseases and to determine the main prenatal determinants of these changes.
Methodology:
A thorough review of recent literature was performed using PubMed, Scopus and Web of Science databases from 2020 to 2026. We reviewed studies on epigenetic mechanisms, fetal programming and long-term cardiometabolic outcomes.

Findings:
There is evidence suggesting adverse perinatal exposures are associated with significant epigenetic changes linked to increased risk for disease. Studies reported around 22% higher risk of metabolic syndrome in offspring exposed to maternal obesity while altered DNA methylation patterns were associated with 17–25% increase in susceptibility to cardiovascular disease in adulthood. Additionally, maternal hyperglycemia and nutritional imbalance were strongly associated with persistent epigenetic changes that affected insulin sensitivity, lipid metabolism and vascular function.

Conclusion:
Perinatal epigenetic modifications have a significant impact on the metabolic and cardiovascular health throughout the lifetime. Prevention strategies that include interventions during pregnancy to target maternal health and environmental exposures may reduce disease susceptibility and promote long-term cardiometabolic health.